Chiyoda Corporation and 東京応化工業 enter into a basic agreement for the commercial deployment of the biomimetic system (MPS) “Fluid3D-X(R)”

Chiyoda Corporation and Tokyo Ohka Kogyo have signed a memorandum of basic agreement aimed at deploying the biomimetic system Fluid3D-X(R) in society. The companies will promote the development and commercialisation of devices using non-PDMS materials.

Full text unavailableWorking from the headline and excerpt

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

Chiyoda Corporation and Tokyo Ohka Kogyo have signed a memorandum of basic agreement aimed at deploying the biomimetic system Fluid3D-X(R) in society.

Fluid3D-X(R) is an MPS device using non-PDMS materials and is reportedly composed of a cell-culture chip and a perfusion culture system.

The two companies aim to achieve deployment in society by promoting the development and commercialisation of the device.

At a glance

EventChiyoda Corporation and Tokyo Ohka Kogyo sign memorandum of basic agreement

SubjectDeployment of the biomimetic system MPS Fluid3D-X in society

FactorsPromoting the development and commercialisation of MPS devices using non-PDMS materials

ObjectivePromoting initiatives toward deployment in society

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

news.nicovideo.jpNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.